Test Price
2,800 AED✅ Home Collection Available
CCND1 Gene Hereditary Colorectal Cancer Susceptibility Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary
• 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS platform.
• VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
• Clinical Guidance: Telephonic post-test interpretation with genetic specialists.
• Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CCND1 (Cyclin D1) gene test uses Next-Generation Sequencing to detect germline mutations that confer hereditary colorectal cancer susceptibility. Performed on blood or FTA card DNA, it identifies at-risk individuals for early surveillance and family counselling.
| Feature | Our Test (NGS Panel) | Single-Gene Sanger Sequencing |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene coverage | Sanger sequencing – targeted exons only |
| Clinical Sensitivity | 99.9% for pathogenic variants | ~85% (misses deep intronic & large rearrangements) |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
| Price (AED) | 2800 | 1500–2000 |
Physician Insight & Safety Protocols
“A positive CCND1 mutation indicates increased lifetime risk, not a cancer diagnosis. I urge all patients to correlate genetic findings with colonoscopy and family history before making any medical decision. Your ongoing care must remain coordinated with your treating oncologist or gastroenterologist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Advisory Notice
Do not discontinue prescribed medications without consulting your doctor. This test is not a substitute for regular colorectal cancer screening.
Exclusion Criteria & Emergency Red Flags
- Not indicated for individuals with active rectal bleeding, acute abdominal pain, or known active malignancy requiring urgent oncology management.
- Seek immediate medical attention if you experience: sudden rectal bleeding, unexplained weight loss >10% body weight, or new-onset persistent abdominal cramping.
- This genetic susceptibility test should never delay life-saving diagnostic colonoscopy or biopsy.
Patient FAQ & Clinical Guidance
1. What is the CCND1 gene test used for?
The CCND1 gene test identifies inherited mutations increasing hereditary colorectal cancer risk, enabling personalized surveillance and prevention. It helps gastroenterologists and genetic counsellors create tailored colonoscopy schedules and risk-reduction plans for entire families.
2. How is the sample collected for this genetic test?
A certified phlebotomist collects a blood sample or a simple finger-prick blood spot on an FTA card in your home, ensuring cold-chain integrity. The sample is transported to our ISO-certified laboratory within 2 hours, maintaining chain of custody.
3. How long do CCND1 NGS results take and what do they include?
Results are delivered within 3 to 4 weeks via a secure patient portal, with genetic counselor interpretation included. The report details any identified pathogenic variants, their clinical significance, and specific NCCN-based surveillance recommendations.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is processed through encrypted channels and stored on UAE-based servers. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified – Certificate INT/EGQ/2509DA/3139
Clinical & Logistical Metadata
| Test Name | CCND1 Gene Hereditary Colorectal Cancer Susceptibility Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or FTA Card (Dried Blood Spot) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Z15.09 (Genetic susceptibility to other malignant neoplasm) |
| LOINC Code | 78999-1 (CCND1 gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians